Compounds > succinobucol
Page last updated: 2024-09-05

succinobucol and Innate Inflammatory Response

succinobucol has been researched along with Innate Inflammatory Response in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, RR; Hoong, LK; Hotema, MR; Howard, RB; Kunsch, C; Landers, LK; Luchoomun, J; MacDOnald, ML; Marino, EM; Meng, CQ; Saxena, U; Sikorski, JA; Simpson, JE; Somers, PK; Stefanopoulos, D; Suen, KL; Sundell, CL; Wasserman, MA; Weingarten, MD; Worsencroft, KJ; Ye, Z; Zheng, XS1
Agbani, EO; Behnisch, B; Czudaj, P; Kennedy, S; McCormick, C; McPhaden, A; Mullen, A; Oldroyd, KG; Wadsworth, RM; Watt, J1
Ransom, J1

Other Studies

3 other study(ies) available for succinobucol and Innate Inflammatory Response

ArticleYear
Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.
    Journal of medicinal chemistry, 2004, Dec-02, Volume: 47, Issue:25

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antioxidants; Cells, Cultured; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Cricetinae; Depression, Chemical; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation; Interleukin-1; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Phenols; Probucol; Structure-Activity Relationship; Sulfides; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2004
Succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:4

    Topics: Animals; Cardiovascular Agents; Cattle; Cell Survival; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Endothelial Cells; Fibrin; Inflammation; Male; Metals; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Percutaneous Coronary Intervention; Probucol; Prosthesis Design; Sirolimus; Swine

2013
Are small biotechs still underselling themselves?
    Nature biotechnology, 2006, Volume: 24, Issue:5

    Topics: Biotechnology; Capital Financing; Drug Industry; Heart; Humans; Inflammation; Investments; Marketing; Myocardium; Probucol; Research Support as Topic; Technology, Pharmaceutical

2006